| Study name |
A trial of Cervidil (dinoprostone, prostaglandin E2 (PGE2), insert) for outpatient pre‐induction of cervical ripening in women at 39.0‐41.6 weeks' gestation |
| Methods |
RCT |
| Participants |
Women, 39 0/7 and 41 6/7 weeks' gestation, undergoing IOL, living within 20 minutes of the facility |
| Interventions |
Outpatient induction with dinoprostone (10 mg) vaginal insert versus inpatient induction with dinoprostone (10 mg) vaginal insert |
| Outcomes |
Primary: time of admission to completion of dilation and total cost of Induction. |
| Starting date |
August 2019 |
| Contact information |
John Nichols, DO, Intermountain Health Care, Inc. Dixie Regional Medical Center, Saint George, Utah, United States, 84790. jnicholsdo@gmail.com. Briana Crook, CRC, bri.crook@imail.org
|
| Notes |
|
